Antitrust Antitrust

Bayer Healthcare urges US judge to dismiss Tevra antitrust complaint over flea, tick treatments

By Michael Acton
  • 03 Nov 2021 15:53
  • 03 Nov 2021 15:53
Bayer Healthcare today urged a US judge in California to dismiss, for the second time, an antitrust lawsuit from Tevra Brands accusing it of illegal exclusive dealing in, and monopolization of, “squeeze-on” flea and tick treatments.

US District Judge Beth Labson Freeman said she had concerns with the market definition in the case,

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

LEARN MORE LEARN MORE

Latest News